- Earth Science Tech is leveraging AI and other technology, along with the expertise of a focused IT department, to drive sustainable growth and ensure long-term value
- The company uses technology to drive down costs, improve operational efficiencies, and expand profit margins within its pharmacy and telemedicine platforms
- ETST also utilizes technology in marketing to increase patient and customer retention and drive brand loyalty
- During the recent Annual Meeting of Shareholders, CTO Chris Rose explained the company’s tech stack and developments that have enabled it to offer its in-house tools to other clinics as a white-label service
Earth Science Tech (OTCQB: ETST) is a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces. The company employs a dedicated IT infrastructure department, led by Chief Technology Officer Chris Rose, that has enabled it to leverage new technology to cut costs, improve operational efficiencies, and expand profit margins across its pharmacy and telemedicine platforms. These benefits, according to Rose, stem from the company’s strategy to build instead of buy and leverage AI to augment the process.
“We build now instead of buy, supported by advancements in and our leverage of AI. We’ve built our own ETST-wide software and data platform that ties together the three pharmacies, our curative telehealth business, and My Online Consultation doctor’s…
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN